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1 Introduction 
One of the fascinating aspects of nanotechnology is that 
on the nanometer scale all the natural sciences meet and 
intertwine. Physics meets life sciences as well as 
tribology, engineering, chemistry, materials science and 
computational approaches, which altogether com-
municate and are closely linked. This inherent 
interdisciplinarity of nanotechnology poses a challenge 
and offers enormous potential for fruitful cross-
fertilisation in specialist areas. [1][2][3].  
A variety of novel nanotechnological techniques such as 
scanning probe microscopy and scanning probe 
spectroscopy allows for accurate characterization and 
manipulation of features down to the single molecule 
level and below [4]. Such techniques are currently 
widely used and continuously being improved, and open 
up completely new perspectives in nearly all fields of 
modern science [5].  
This manuscript introduces two prominent research 
areas at the meeting place of life sciences with 
engineering and physics: nanomedicine and bio-
mimetics. The foundations of both areas are presented 
and current research methodologies and results are 
introduced. The outlook of this paper features concepts 
with wide ranging implications for understanding the 
processes in living beings as well as possible 
applications in engineering and medicine.    
However, with the huge knowledge in different fields, 
nowadays it is impossible for a single person to know 
and understand more than just a fraction. Nevertheless, 
the awareness and understanding of different 
approaches and concepts is a paramount prerequisite of 
interdisciplinary work. A common language of bio-
logists, professionals from medicine and pharmaceutics 
as well as engineers and natural scientists, in which 
descriptions at different level of detail are more 
compatible, is desirable.  
1.1 Nanomedicine  
Nanomedicine is an emerging field that is continuously 
gaining importance (Fig. 1). One of the pioneers of 
nanomedicine is Robert A. Freitas Jr. His two books on 
the field are recommended literature for getting 
introduced to basic concepts and high-flying visions and 
ideas [6][7].  
The human body consists of ~7*1027 atoms arranged in 
a highly aperiodic physical structure. Although 41 
chemical elements are commonly found in the body, C, 
H, O and N comprise 99% of its atoms. Fully 87% of 
human body atoms are either hydrogen or oxygen. [6]  
Atoms in the human body are generally present in 
combined form as molecules or ions, not individual 
atoms. The molecules of greatest nanomedical interest 
are incorporated into cells or circulate freely in blood 
plasma or the interstitial fluid. The typical human cell is 
99.5% water and salts, by molecule count, and contains 
~5000 different types of molecules. The human body is 
comprised of ~105 different molecular species, mostly 
proteins - a large but nonetheless finite molecular parts 
list. By 1998, at least ~104 of these proteins had been 
sequenced, ~103 had been spatially mapped, and ~7,000 
structures (including proteins, peptides, viruses, 
protein/nucleic acid complexes, nucleic acids, and 
carbohydrates) had been registered in the Protein Data 
Bank which at that time was maintained at Brookhaven 
National Laboratory. Given the current accelerating 
pace of improving technology, it is likely that the 
sequences and 3D or tertiary structures of all human 
proteins will have been determined by the second 
decade of the 21st century. [6] 
The Foresight Institute is a California based think tank 
and public interest institute on nanotechnology. 
Founded in 1986, the Foresight Institute was the first 
organization to educate society about the benefits and 
risks of nanotechnology.   
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Figure 1: The number of scientific publications with 
“nanomedicine” as topic or in the title.   
Source: ISI Web of Knowledge, Thomson Reuters. 
http:// www.webofknowledge.com 
 
Foresight’s mission is to ensure the beneficial 
implementation of nanotechnology. Their internet page 
gives sound overview on current topics in nanotech-
nology, and their nanomedicine part is well written.  
“Nanomedicine may be defined as the monitoring, 
repair, construction and control of human biological 
systems at the molecular level, using engineered 
nanodevices and nanostructures. 
Basic nanostructured materials, engineered enzymes, 
and the many products of biotechnology will be 
enormously useful in near-term medical applications. 
However, the full promise of nanomedicine is unlikely 
to arrive until after the development of precisely 
controlled or programmable medical nanomachines and 
nanorobots. 
Such microscopic machines were first hypothesized by 
the Nobel-winning physicist Richard Feynman in 1959, 
and later were described at length by K. Eric Drexler in 
his popular books Engines of Creation (1986) and 
Unbounding the Future (1991), and in his more recent 
technical book Nanosystems: Molecular Machinery, 
Manufacturing, and Computation (1992).” 
http://www.foresight.org/nanomedicine   [8][9][10][11] 
A deeper understanding of the fundamental principles of 
nature itself will provide new ways and possibilities for 
influence of and interaction with biological systems. 
Nanotechnology already has and will to an increasing 
degree have an impact on the medical research in the 
future. Although new diagnostic tools and improved 
ways of drug administration have already been 
developed as a first fruit of the upcoming nano-era, still 
many challenges and problems remain unsolved and the 
technology is far from using the wide variety of 
opportunities offered. 
To meet this demanding task, nanomedicine like no 
other area of research requires a close collaboration of 
people from technology and biology, and only a 
thoroughly linked network will be able to bring this 
novel sector to its full potential. [12][13] 
For primary literature in the field, the Elsevier Journal 
“Nanomedicine: Nanotechnology, Biology and 
Medicine” and the American Scientific Publishers 
“Journal of Biomedical Nanotechnology” (both founded 
in 2005) are recommended. These are international, 
peer-reviewed journals that cover basic, clinical, and 
engineering research in the field of nanomedicine.  
1.2 Biomimetics 
Biomimetics is a continuously growing field (Fig. 2) 
[1][14][15]. Biomimetics deals with the realization of 
processes and construction, as well as the development 
of principles of nature in technological applications and 
devices, i.e. there is a transfer (of knowledge) from 
biology to technology. It is worth noting that identical 
copies from nature to technology are not feasible in 
biomimetics. Instead, biomimetics encompasses a 
creative conversion into technology that is often based 
on various steps of abstractions and modifications, i.e. 
an independent successive construction that is rather a 
‘new invention’ than a blueprint of nature [16][17].  
 
Figure 2: The number of scientific publications with 
“biomim*” as topic or in the title.   
Source: ISI Web of Knowledge, Thomson Reuters. 
http:// www.webofknowledge.com 
 
The history of biomimetics can be traced back at least to 
the flying machines of L. daVinci during renaissance 
times. In the mid-20th century O.H. Schmitt coined the 
term “biomimetics”. Schmitt and his wife studied 
natural biological processes and invented methods and 
machines that duplicated those actions. This new 
science became known as “Biomimetics” or “The 
Mimicry of Nature.” Their research into squid nerves 
led to the patented “Schmitt Trigger” [18]. The word 
bionics was originally coined by J.E. Steele at about the 
same time and indicated a blend of biology and 
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electronics. In German the term ‘Bionik’ (blend of 
biology and technics) is used.  
The classification of the single subfields within 
biomimetics is not yet standardized. Based on the work 
of Nachtigall [17], the field can be subdivided as 
follows: construction biomimetics, process (or 
procedure) biomimetics, and information biomimetics. 
The structure and function of biological systems are 
studied as models for the design and engineering of 
materials and machines. Principles and abstract ideas of 
natural phenomena and model systems are extracted and 
applied to technical applications and design (Fig. 3).  
General principles that can be applied by engineers who 
are not at all involved in biology are  
 integration instead of additive construction, 
 optimization of the whole instead of 
maximization of a single component feature, 
 multi-functionality instead of mono-
functionality, 
 energy efficiency and 
 development via trial-and-error processes.  
 
Systematic technology transfer from biology to 
engineering thereby becomes generally accessible. 
 
Figure 3: Biomimetics: principles and abstract ideas of 
natural phenomena and model systems are extracted 
and applied to technical applications and design. © 
2008 by P. Gruber, transarch. 
 
Strategies and technologies for entering an ecological 
age comprise the following biomimetics principles: 
 Use waste as a resource, 
 use materials sparingly and do not draw down 
resources, 
 diversify and cooperate, 
 gather and use energy efficiently, 
 clean up not pollute,  
 remain in balance with the biosphere and 
 use local resources. 
In June 2008 the Center of Excellence for Biomimetics, 
TU BIONIK (for logo see Fig. 4) was founded at the 
Vienna University of Technology by Herbert 
Stachelberger from Chemical Engineering, Heinz-Bodo 
Schmiedmayer from Mechanical Engineering, Petra 
Gruber from Architecture and Ille C. Gebeshuber from 
Physics Engineering.  
 
Figure 4: Logo of TU BIONIK, the Center of Excellence 
for Biomimetics at the Vienna University of Technology. 
 
TU BIONIK comprises more than 30 researchers from 
all faculties, covering an impressive range of fields:  
Architecture and Planning:  
Architectural Design, Architecture Theory, 
Biomimetics, Sustainable and efficient Building 
Construction, Biomaterials in Architecture, Digital 
Architecture and Planning. 
Civil Engineering:  
Biomechanics, Dynamic Behaviour of Biomechanical 
Systems. 
Electrical Engineering and Information Technology: 
Biocompatibility of Surfaces, Micro-und Nanostructure 
Technology, Microsystems Technology, Construction 
Methodology, Cognitive Information Processing, 
Industrial Sensor Systems. 
Informatics:  
Evolutionary Computation. 
Mechanical and Industrial Engineering:   
Nanoarchitecture of Biomaterials, Biomineralisation, 
Biomechanics, Non Metallic Materials, Simulation of 
dynamic Multibody Systems, Interaction Human-
Technical System. 
Mathematics and Geoinformation:  
Spatial cognition, Computational Neuroscience and 
Biomedical Engineering. 
Physics: 
(Bio)Nanotechnology, Tribological Micro- and 
Nanosystems of the Biosphere, Engineering Biology. 
Technical Chemistry:  
Characterisation of Biopolymers, Natural Products and 
Food Chemistry, Fibre technology, Mechanical Process 
Engineering. 
The aim of TU BIONIK is to combine existing 
competencies and to develop new ones. A trans-
disciplinary research facility shall be established, and 
the existing activities at the TU Wien shall be 
crosslinked. Furthermore, sponsorship for the network 
as well as project funding shall be acquired, and cross-
linking with Austrian and international activities such as 
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the BIONIS network in the UK shall take place. The 
joint internet appearance of the groups involved is 
http://biomimetics.tuwien.ac.at/ and will feature 
background information as well an ongoing projects and 
research attempts. 
2 Methods 
2.1 Nanosized Drug Delivery Systems: Particle 
Mediated Delivery Strategies  
The roots of particle aided drug delivery range back to 
the beginning of the 20th century, when Paul Ehrlich 
introduced the concept of ‘magic bullets’ that should be 
able to attack selectively the “bad cells” in a diseased 
human body, leaving the healthy parts of the organism 
undisturbed. Inspired by the plot of a classical opera he 
established the principle of targeted drug delivery, and 
for the first time he pinpointed the problematic issues 
that up to now occupy scientists working on the field. 
What was merely a visionary idea in the days of Paul 
Ehrlich has meanwhile come to practical realization, 
greatly fostered by the striking advancements on the 
(bio)nanotechnological sector of engineering and life 
science. While at present being still in its infancies, 
particle mediated delivery strategies will finally open 
the way for a far more specific and compliant treatment 
of numerous diseases. 
The technology available today facilitates the 
entrapment of pharmaceutically active ingredients or 
imaging markers in the matrix of micro- or nanometer 
sized carriers, which then release their content at the site 
of disease. In addition to temporally controlled 
liberation behaviour, the unique advantage lies in the 
possibility to modify the particles’ surface so they 
adhere selectively to an intended target tissue [19]. This 
allows for addressing a multitude of problematic 
therapeutic questions, ranging from uptake-enhancing 
formulations for poorly bioavailable drugs to the highly 
specific targeting of bacteria or cancer cells [20].  
Malignant tumours can thus be identified in an earlier 
stage of progression and patients be provided with a 
more fortunate prognosis. Shielding the healthy tissue 
from adverse effects, higher potent antiproliferative 
drugs can be administered. In future, the treatment of 
cancer may further be improved by applying the concept 
of ‘theranostics’ that comprises simultaneous diagnosis 
and medication of diseased cells via multifunctional 
carriers [21]. 
Clinical trials on superparamagnetic nanoparticles that 
can be used to image and externally heat up tumour 
tissue have led to promising initial results [22]. 
Conceptual designs of higher complexity suggest the 
development of nanosized functional entities that 
dynamically respond to changes in the physiological 
state while circulating in the human body. Someday, 
medical nanorobots could be in use to monitor certain 
parameters of their environment and release 
encapsulated substances upon pathological stimulation. 
Insulin containing reservoirs that automatically react to 
the blood glucose level or drug carriers that sense the 
acidic microenvironment in cancer tissue might become 
available by the future advancement of 
bionanotechnology. However, much developmental 
work remains to be done before these ambitious goals 
will be reached.  
2.2 Biomimicry Innovation Method  
The large biodiversity in rainforests holds enormous 
potential for inspiring emerging technologies as well as 
optimising existing ones. Biomimicry is an innovation 
method that seeks sustainable solutions by emulating 
nature's time-tested patterns and strategies, e.g., a solar 
cell inspired by a leaf or noise reduction in aircraft 
inspired by parasitic flies of cicadas. The goal is to 
create products, processes, and policies - new ways of 
living - that are well adapted to life on earth over the 
long haul. 
The Biomimicry Innovation Method (© Biomimicry 
Guild, Helena, MT, USA 2008) involves specifically 
trained biologists as well as engineers, natural scientists, 
architects and/or designers from universities or 
companies. The Biomimicry Innovation Method is for 
example used in the rainforest (high species variety, 
high innovation potential) to learn from and emulate 
natural models (http://www.biomimicryguild.com/).  
The steps in the biomimicry process are as follows:  
 Identify function, 
 biologize the question, 
 find nature’s best practices and 
 generate product ideas. 
 
Identify Function:  
The biologists distil challenges posed by 
engineers/natural scientists/architects and/or designers 
to their functional essence. 
Biologize the Question:  
In the next step, these functions are translated into 
biological questions such as “How does nature recover 
fresh water from salt water?” or “How does nature bond 
two dissimilar materials?” The basic question is “What 
would nature do here?” 
Find Nature’s Best Practices:  
Scientific data bases as well as the surrounding 
rainforest are used to obtain a compendium of how 
plants, animals and ecosystems solve the specific 
challenge. 
Generate Process/Product Ideas:  
From these best practices (90% of which are usually 
new to clients), the biologists generate ideas for cost-
effective, innovative, life-friendly and sustainable 
products and processes. 
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3 Application of the Methods 
3.1 Biomimicry in Nanomedicine 
In the sense of emulating naturally given structures and 
construction principles in order to profit from the related 
functional behaviour, many tasks in nanomedicine may 
be regarded as a specialized subdivision of in-body 
biomimicry. 
For the growing fields of tissue engineering and 
endoprosthesis technology, durable engraftment still 
poses a major problem as artificial surfaces often show 
insufficient biological compliance. Pioneering recent 
studies found that the configuration of nanometer 
surface features can greatly facilitate cell adhesion, with 
an increasing extent the closer the surface structure 
resembles the natural microenvironment [23]. 
The regulation of cells in terms of growth and 
differentiation is remarkably affected by the structural 
and mechanical constitution of their underlying 
substrate, and nanopattering will thus be of primary 
importance for the successful development of cell-based 
therapies [24][25]. As cells “feel” their surrounding at 
the micro- and submicrometer length scale, also a 
manipulation of the respective surface features to 
influence cellular behaviour has to be carried out at this 
dimension. 
In an attempt to counteract the rapid clearance of 
nanometer sized drug delivery devices by the immune 
system, it has been recognized that a coating with 
macromolecular hydrophilic chains such as 
polyethylene glycol prevents opsonisation and thus 
macrophagic uptake. Strikingly, it was found that 
certain types of biomolecules can intercalate with these 
chains and thus result in a particle that closely 
resembles the structure of endogenous low-density 
lipoprotein spheres, which finally leads to an enhanced 
uptake across the blood brain barrier [26]. By 
mimicking the physicochemical appearance of 
endogenous structures, artificial carriers may thus be 
able to utilize physiological transport mechanisms 
present in the human body. 
3.2 Applying the Biomimicry Innovation Method: 
The BioScreen Project 
The TU BIONIK project BioScreen analyses the rich 
flora in South East Asia (especially Borneo) concerning 
its biomimetic inspirational potential for technological 
applications.  
A central aspect in the implementation of the project is 
the cooperation between institutions in the European 
Union, especially in Austria, with local institutions in 
South East Asia, especially Malaysia. Increasing 
awareness about the technological innovation potential 
of the rainforest and its abundance of species might 
cause a paradigm shift in the way locals view the 
pristine forests.  
BioScreen is a pilot project with one major task: the 
installation of collaborations between key institutions 
that shall then serve as base for further projects.  
BioScreen is conducted by Herbert Stachelberger from 
the Institute of Chemical Engineering at the Vienna 
University of Technology, and Ille C. Gebeshuber, who 
is currently on leave from the Vienna University of 
Technology, working as Professor of Nanotechnology 
and Biomimetics at the Institute of Microengineering 
and Nanoelectronics (IMEN) at the Universiti 
Kebangsaan Malaysia. Both are founding members of 
TU BIONIK. 
BioScreen is performed in cooperation with the Forest 
Research Institute Malaysia (http://www.frim.gov.my) 
and Prof. Burhanuddin Yeop Majlis, chairman of the 
National Nanotechnology Association of Malaysia and 
director of IMEN. 
4 Future Perspectives 
The high degree of specialization in current science and 
technology requires a cross-disciplinary dialogue to 
prevent re-invention of the wheel. Nanomedicine and 
biomimetics are rapidly growing interdisciplinary fields. 
However, there is still a cleft in the conceptual worlds 
and in the attitudes as well as languages of researchers 
in the fields involved (in many cases originating from 
early education). Educating a number of people in a 
more interdisciplinary way is a promising first step 
towards reaching the goal of a common language.  
4.1 Nanomedicine 
Nanotechnology is beginning to change the scale and 
methods of medical imaging and drug delivery. The 
American National Institute of Health states in its 
“Nanomedicine Initiative Roadmap” that the 
development of nanoscale laboratory-based diagnostic 
and drug discovery platform devices such as nanoscale 
cantilevers for chemical force microscopes, microchip 
devices, nanopore sequencing, etc. shall yield generally 
usable devices within less than ten years [27]. 
Nanometer scale multifunctional entities that can 
diagnose, deliver therapeutic agents, and monitor cancer 
treatment progress are current hot topics of research 
[28]. These include design and engineering of targeted 
contrast agents that improve the resolution of cancer 
cells to the single cell level, and nanodevices capable of 
addressing the biological and evolutionary diversity of 
the multiple cancer cells that make up a tumor within an 
individual.  
Thus, for the full in vivo potential of nanotechnology in 
targeted imaging and drug delivery to be realized, 
nanocarriers have to get smarter [29]. Pertinent to 
realizing this promise is a clear understanding of both 
physicochemical and physiological processes. These 
form the basis of complex interactions inherent to the 
fingerprint of a nanovehicle and its microenvironment. 
Inherently, carrier design and targeting strategies may 
vary in relation to the type, developmental stage, and 
location of the disease. Toxicity issues are of particular 
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concern but are often ignored. Therefore, it is essential 
that fundamental research be carried out to address these 
issues if successful efficient application of these 
technologies is going to be achieved [30][31].  
Rapid progress in the recent years gave proof of the 
benefits and enormous potential lying in the 
implementation of nanotechnology in the biomedical 
sector, but many promising approaches have so far not 
been able to exceed beyond the conceptual stage. This 
can be attributed to a still insufficient understanding of 
the basic principles that govern the interaction 
behaviour of nanosized entities and living tissue, which 
is also associated with a certain fear for ‘nano’-toxic 
side effects.  Further elucidation on this issue - 
preferentially conducted by interdisciplinary 
overlapping research collaborations - is thus urgently 
required to set the solid basis for a successful 
development of novel nanomedical therapy concepts in 
the future. 
4.2 Biomimetics 
Biomimetics can help to create products and processes 
that are sustainable, perform well, save energy, cut 
material costs, redefine and eliminate “waste”, heighten 
existing product categories, define new product 
categories and industries, drive revenue and build 
unique brands: 
Sustainability:  
Biomimetics that follows “life’s principles” [32] (i.e. 
build from the bottom up, self-assemble, optimize rather 
than maximize, use free energy, cross-pollinate, 
embrace diversity, adapt and evolve, use life-friendly 
materials and processes, engage in symbiotic 
relationships, and enhance the bio-sphere) yields 
sustainable products and processes. 
Performance:  
In nature, if a strategy is not effective, its carrier dies. 
Nature has been vetting strategies for 3.8 billion years. 
Biomimetics helps to study the successful strategies of 
the survivors and to perform well. 
Energy:  
Energy in the natural world is even more expensive than 
in the human world. Plants have to trap and convert it 
from sunlight and predators have to hunt and catch it. 
As a result of the scarcity of energy, life tends to 
organize extremely energy efficient designs and 
systems, optimizing energy use at every turn. Emulating 
these efficiency strategies can dramatically reduce the 
energy use of biomimetic devices.  
Materials Costs: 
Nature builds to shape, because shape is cheap and 
material is expensive. By studying the shapes of 
nature’s strategies and how they are built, biomimetics 
can help minimize the amount spent on materials while 
maximizing the effectiveness of products patterns and 
forms to achieve their desired functions. 
Waste Management:  
By mimicking how nature transitions materials and 
nutrients within a habitat, units and systems can be set 
up to optimally use resources and eliminate unnecessary 
redundancies. Organizing habitat flows more similarly 
to nature’s will drive profitability through cost savings 
and/or the creation of new profit centers focused on 
selling waste to companies who desire “waste” as a 
feedstock (e.g. plastic bags from waste disposal sites are 
valuable feedstock material for the cement industry). 
Heighten existing product categories:  
Biomimetics might help to see stale product categories 
in a radically different light, creating opportunities for 
innovation. 
Define new product categories and industries:  
Biomimetics can help to create disruptive technologies 
that transform technology or help build entirely new 
industries. 
Drive Revenue:  
Biomimetics can help create whole new growth areas, 
reignite stale product categories and attract both 
customers who care about innovation and sustainability. 
Build Unique Brands:  
Creating biomimetic products and processes will help to 
become known as both innovative and proactive about 
the environment.  
Pursuing a biomimetic approach may be a path for 
realizing simultaneously ‘smart’, dynamic, complex and 
environmentally friendly products and processes. 
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